000			01683cam a22004814a 4500
001			14758547
003			BD-DhUL
005			20150121151247.0
008			070302s2007 nyua b 001 0 eng
010			_a 2007008964
015			_aGBA720727 _2bnb
016	7		_a101300739 _2DNLM
016	7		_a013694593 _2Uk
020			_a9780824729455 (hb : alk. paper)
020			_a0824729455 (hb : alk. paper)
035			_a(OCoLC)ocm85817916
035			_a(OCoLC)85817916
040			_aDNLM/DLC _cDLC _dNLM _dBAKER _dBTCTA _dYDXCP _dC#P _dUKM _dMUQ _dDLC _dBD-DhUL
042			_apcc
050	0	0	_aRS201.E87 _bO73 2007
060	0	0	_aW1 _bDR893B v.170 2007
060	1	0	_aQV 38 _bO635 2007
082	0	0	_a615.1 _bORA
245	0	0	_aOral lipid-based formulations : _benhancing the bioavailability of poorly water-soluable drugs / _ced. by David J. Hauss.
260			_aNew York : _bInforma Healthcare, _cc2007.
300			_axii, 339 p. : _bill. ; _c24 cm.
365			_aS$ _b174.91
490			_aDrugs and the pharmaceutical sciences ; _vv. 170.
504			_aIncludes bibliographical references and index.
650		0	_aLipids _xTherapeutic use.
650		0	_aDrugs _xSolubility.
650		0	_aSolutions (Pharmacy)
650		0	_aDrugs _xDosage forms.
650	1	2	_aBiological Availability.
650	1	2	_aSolubility _xdrug effects.
650	2	2	_aDosage Forms.
650	2	2	_aDrug Administration Routes.
650	2	2	_aDrug Delivery Systems _xmethods.
700	1		_aHauss, David J.
906			_a7 _bcbc _corignew _d1 _eecip _f20 _gy-gencatlg
942			_2ddc _cBK
955			_ajc00 2007-03-06 _aaa27 2007-03-07 _aps10 2007-10-03 1 copy rec'd., to CIP ver. _axh13 2009-07-01 copy 2 added
999			_c34628 _d34628